scholarly article | Q13442814 |
P2093 | author name string | Oriol R | |
Larson G | |||
Mollicone R | |||
Van den Eijnden DH | |||
Van Dijk W | |||
Brinkman-Van der Linden EC | |||
P2860 | cites work | A cloned human cDNA determines expression of a mouse stage-specific embryonic antigen and the Lewis blood group alpha(1,3/1,4)fucosyltransferase | Q24318318 |
Expression of human chromosome 19p alpha(1,3)-fucosyltransferase genes in normal tissues. Alternative splicing, polyadenylation, and isoforms | Q28295888 | ||
Five specificity patterns of (1----3)-alpha-L-fucosyltransferase activity defined by use of synthetic oligosaccharide acceptors. Differential expression of the enzymes during human embryonic development and in adult tissues | Q28316034 | ||
Acceptor specificity of different length constructs of human recombinant alpha 1,3/4-fucosyltransferases. Replacement of the stem region and the transmembrane domain of fucosyltransferase V by protein A results in an enzyme with GDP-fucose hydrolyzi | Q30981873 | ||
Elevated levels of abnormally-fucosylated haptoglobins in cancer sera | Q36028472 | ||
Inflammation-induced expression of sialyl Lewis X-containing glycan structures on alpha 1-acid glycoprotein (orosomucoid) in human sera | Q36361464 | ||
Purification, properties and possible gene assignment of an alpha 1,3-fucosyltransferase expressed in human liver | Q41262375 | ||
Cancer-associated elevation of α(1 → 3)-l-fucosyltransferase activity in human serum | Q43575585 | ||
Alterations in the carbohydrate moiety of alpha-1-acid glycoprotein purified from human cirrhotic ascitic fluid | Q43925837 | ||
Crossed immuno-affinoelectrophoresis. An analytical method to predict the result of affinity chromatography | Q47932885 | ||
Acceptor specificity and tissue distribution of three human alpha-3-fucosyltransferases | Q48932467 | ||
Determination of the primary structures of 16 asialo-carbohydrate units derived from human plasma alpha 1-acid glycoprotein by 360-MHZ 1H NMR spectroscopy and permethylation analysis | Q67427242 | ||
400-MHz 1H-NMR spectroscopy of fucosylated tetrasialyl oligosaccharides isolated from normal and cirrhotic alpha 1-acid glycoprotein | Q67929308 | ||
Glycosylation of three molecular forms of human alpha1-acid glycoprotein having different interactions with concanavalin A. Variations in the occurrence of di-, tri-, and tetraantennary glycans and the degree of sialylation | Q68466013 | ||
Studies on the effect of the hepatocyte-stimulating factor on galactose-beta 1----4-N-acetylglucosamine alpha 2----6-sialyltransferase in cultured hepatocytes | Q68860460 | ||
Tumor-related elevation of serum (alpha 1----3)-L-fucosyltransferase activity in gastric cancer | Q69375378 | ||
Activity and secretion of sialyltransferase in primary monolayer cultures of rat hepatocytes cultured with and without dexamethasone | Q69539765 | ||
Structure determination of the glycans of human-serum alpha 1-antichymotrypsin using 1H-NMR spectroscopy and deglycosylation by N-glycanase | Q70138801 | ||
Structural analysis on the sugar chains of human alpha 1-antitrypsin: presence of fucosylated biantennary glycan in hepatocellular carcinoma | Q70460313 | ||
Increased plasma alpha (1 --> 3)-L-fucosyltransferase activities in patients with hepatocellular carcinoma | Q70986859 | ||
Glycosylation of alpha 1-acid glycoprotein in septic shock: changes in degree of branching and in expression of sialyl Lewis(x) groups | Q71481078 | ||
Stability of blood coagulation factors and inhibitors in blood drawn into half-strength citrate anticoagulant | Q71690975 | ||
The use of human milk fucosyltransferase in the synthesis of tumor-associated trimeric X determinants | Q72233915 | ||
P433 | issue | 24 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 14492-14495 | |
P577 | publication date | 1996-06-01 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | A missense mutation in the FUT6 gene results in total absence of alpha3-fucosylation of human alpha1-acid glycoprotein | |
P478 | volume | 271 |
Q35648842 | A fluorescent bisboronic acid compound that selectively labels cells expressing oligosaccharide Lewis X. |
Q34346443 | ABH and Lewis histo-blood group antigens, a model for the meaning of oligosaccharide diversity in the face of a changing world |
Q38344428 | Advances in molecular genetics of alpha-2- and alpha-3/4-fucosyltransferases. |
Q35027094 | Alpha(1)-acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties |
Q38314147 | Alteration of sugar chains on alpha(1)-acid glycoprotein secreted following cytokine stimulation of HuH-7 cells in vitro |
Q30724288 | Altered glycosylation of alpha1-acid glycoprotein in patients with inflammation and diabetes mellitus |
Q40624595 | Complement Regulatory Protein C1 Inhibitor Binds to Selectins and Interferes with Endothelial-Leukocyte Adhesion |
Q44787125 | Distinct glycoforms of human alpha1-acid glycoprotein have comparable synthesis rates: a [13C]valine-labelling study in healthy humans |
Q73568460 | Do synovial fluid acute phase proteins from patients with rheumatoid arthritis originate from serum? |
Q33687866 | Evolutionary considerations in relating oligosaccharide diversity to biological function |
Q36050468 | Fucosylated Glycans in α1-Acid Glycoprotein for Monitoring Treatment Outcomes and Prognosis of Cancer Patients |
Q30821619 | Fucosylation of N-glycans regulates the secretion of hepatic glycoproteins into bile ducts |
Q33784627 | Genomics meets glycomics-the first GWAS study of human N-Glycome identifies HNF1α as a master regulator of plasma protein fucosylation |
Q38333345 | Human alpha1,3/4-fucosyltransferases. III. A Lys/Arg residue located within the alpha1,3-FucT motif is required for activity but not substrate binding |
Q71870443 | Identification of a new plasma alpha(1,3)fucosyltransferase (FUT6) allele requires an extended genotyping strategy |
Q40907008 | Identification of two functionally deficient plasma alpha 3-fucosyltransferase (FUT6) alleles |
Q35876153 | In vivo clearance of alpha-1 acid glycoprotein is influenced by the extent of its N-linked glycosylation and by its interaction with the vessel wall. |
Q43580839 | Increased alpha3-fucosylation of alpha(1)-acid glycoprotein in patients with congenital disorder of glycosylation type IA (CDG-Ia). |
Q43768088 | Increased alpha3-fucosylation of alpha1-acid glycoprotein in Type I diabetic patients is related to vascular function |
Q34575757 | Interleukin-1beta induces sialyl Lewis X on hepatocellular carcinoma HuH-7 cells via enhanced expression of ST3Gal IV and FUT VI gene |
Q22254625 | Localization of alpha 1,3-fucosyltransferase VI in Weibel-Palade bodies of human endothelial cells |
Q77768693 | Severe rheumatoid arthritis prohibits the pregnancy-induced decrease in alpha3-fucosylation of alpha1-acid glycoprotein |
Q42541975 | Sialyl Lewis(x) epitopes do not occur on acute phase proteins in mice: relationship to the absence of alpha3-fucosyltransferase in the liver |
Q41048755 | Studies on the interaction between hyaluronan and a rat colon cancer cell line |
Q47975101 | The gain-of-function Chinese hamster ovary mutant LEC11B expresses one of two Chinese hamster FUT6 genes due to the loss of a negative regulatory factor |
Q92668985 | Tri-antennary tri-sialylated mono-fucosylated glycan of alpha-1 antitrypsin as a non-invasive biomarker for non-alcoholic steatohepatitis: a novel glycobiomarker for non-alcoholic steatohepatitis |
Q77103904 | Tumor cells as the origin of elevated serum alpha1,3fucosyltransferase in association with malignancy |
Q43779024 | Tumor necrosis factor alpha increases the expression of glycosyltransferases and sulfotransferases responsible for the biosynthesis of sialylated and/or sulfated Lewis x epitopes in the human bronchial mucosa |
Q45146173 | alpha1-acid glycoprotein fucosylation as a marker of carcinoma progression and prognosis |
Search more.